CTLT: Nilai perusahaan marang bathi resik Catalent, Inc

Catalent, Inc - logo grafis emiten CTLT

The price action chart on GURU.Markets shows the P/E ratio for Catalent, Inc. (CTLT) at -28.20. Management is currently focusing on implementing new regulations following a large-scale asset merger. Business profitability relies on the intensive operation of biologic fill-finish lines and adherence to strict quality standards. High productivity is achieved through the implementation of automated systems that eliminate manual labor during dose packaging.

CTLT: Pangali P/E Catalent Pharma Solutions 04.07.2022 - 21.12.2024

Rincian analitis perusahaan Catalent Pharma Solutions (CTLT)

- rega lan prakiraan konsensus rega:
Rega saham catalent.com|CTLT - Target konsensus
- informasi kapitalisasi pasar:
Nilai pasar Catalent, Inc.|CTLT - Rega Nyata Tumbas Perusahaan Kanthi Wutuh
- indikator nilai aset resik miturut neraca:
Rega Buku Saham Catalent|CTLT - Kapitalisasi Buku|Koefisien Nilai Pasar marang Nilai Buku catalent.com|CTLT - Aset Agregat Perusahaan
- statistik kawajiban utang lan likuiditas:
Koefisien Total Utang marang Modal Catalent, Inc.|CTLT - Rasio utang jangka dawa marang ekuitas|Rasio silihan jangka cendhak marang modal Catalent, Inc|CTLT - Utang perusahaan|Utang-utang marang aset resik Catalent, Inc.|CTLT - Utang jangka dawa perusahaan|Kewajiban jangka cendhak perusahaan Catalent|Rasio cepet catalent.com
- informasi bathi lan kelipatan valuasi:
CTLT - Penghasilan resik|Bathi resik mangsa ngarep Catalent, Inc.|CTLT - Pangali P/E|Pangali Forward P/E Catalent Inc.|CTLT - Rasio rega marang bathi tumrap wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Catalent, Inc.|CTLT - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan Catalent|CTLT - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan catalent.com|CTLT - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Catalent, Inc.
Analisis komprehensif perusahaan:Catalent, Inc.
Produk asil prodhuksi Catalent Inc.

Catalent, Inc. holds a dominant position in the CDMO sector, making it a strategic asset for Novo Holdings. The company's forward P/E reflects the business value through the ratio of market capitalization to net income. This multiple determines the investment payback period assuming constant income levels. Analysis of the curve allows for the identification of cyclical undervaluation or asset overheating. Given the $16.5 billion acquisition, the indicator's dynamics confirm the fairness of the premium paid for manufacturing capacities.

Pesaing wigati

Pangali P/E iqvia.com|Koefisien rega marang bathi LH (Labcorp)|MEDP (Medpace Holdings) - Nilai perusahaan marang bathi resik|iconplc.com - Koefisien rega marang bathi|Rasio rega pasar marang bathi resik CRL (Charles River Corp)|Evotec SE - Pangali P/E|Kapitalisasi marang bathi fortrea.com|lifecore.com (LFCR) - Rasio rega marang bathi|OABI - Periode bali modal bisnis|Koefisien rega marang bathi NOTV|CDMO (Avid Bioservices Inc) - Rasio rega pasar marang bathi resik|Rasio rega marang bathi Scorpius Holdings, Inc. (SCPX)